CD8+ T cell negative selection kits (Miltenyi Biotec) were used to isolate peripheral T cells from mouse spleens (39). To analyze tumor-infiltrating T cells, the tumors were first digested with collagenase IV (Sigma-Aldrich), and then the tumor-infiltrating leukocytes were isolated by centrifugation at 40%–70% Percoll (GE) gradient. To measure the effector function of CD8+ T cells, T cells were first incubated in the presence of 5 μg/mL BFA with 1 μM ionomycin and 50 ng/mL PMA for 5 hours, then stained with APC/Cy7 conjugated anti-CD8a antibody (BioLegend, then stained with APC/Cy7 CD8a antibody (BioLegend, catalog 100714 for mouse, and catalog 300926 for human). Cells were then fixed and permeabilized with 4% paraformaldehyde (PFA) and stained with APC anti-IFN-γ antibody (Biolegend, catalog 505810 for mouse, and catalog 502512 for human), PE anti-TNF-α antibody (Biolegend, catalog 506306 for mouse, and catalog 502909 for human), and PerCP/Cyanine5.5 anti-human/mouse Granzyme B (BioLegend, catalog 372212. Generally, in order to gate cytokines or granule-producing cells, unstimulated T cells or T cells stained by an isotype control antibody were used as negative controls. This gating strategy was applied in all the flow cytometry analyses unless otherwise indicated.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.